IHCDA is proposed, an information-enhanced and heterogeneity-aware learning model for circRNA-disease association prediction that introduces auxiliary relational structures to enhance sparse similarity information by incorporating structural relational knowledge, and seamlessly integrates it into the representation learning process.
Abstract
Circular RNAs (circRNAs) are increasingly recognized for their roles in complex diseases; however, identifying circRNA-disease associations remains challenging due to the high cost of experimental validation and the sparsity of known associations. Existing models often suffer from insufficient information and fail to effectively model heterogeneity across different data representations, including the complementary semantic and structural characteristics of multi-view data, which limits their performance. To address these issues, we propose IHCDA, an information-enhanced and heterogeneity-aware learning model for circRNA-disease association prediction. Unlike existing models that loosely combine multiple techniques, IHCDA introduces auxiliary relational structures to enhance sparse similarity information by incorporating structural relational knowledge, and seamlessly integrates it into the representation learning process. Furthermore, heterogeneous multi-view representations are adaptively modeled via view-specific attention mechanisms, and a semi-supervised contrastive learning strategy is designed to jointly optimize intra-view and cross-view relationships on the enhanced representations. Extensive experimental results demonstrate that IHCDA achieves competitive performance in circRNA-disease association prediction. Furthermore, case studies validate its effectiveness, reliability, and stability in identifying potential associations.
NAF-CDA is proposed, a node-adaptive robust fusion framework for circRNA-disease association prediction that constructs multi-source similarity networks from association profiles, circRNA functional information, and disease semantic information, followed by an adaptive fusion strategy to integrate complementary biologi...
Yun Zhou, Chun-Yun Song, Wen-Bo Cai et al.· Computational biology and ch...· 0 citations
circRNA−miRNA interactions (CMIs) regulate downstream gene expression through the miRNA sponge mechanism and contribute to the progression of various diseases. Although computational methods have advanced the prediction of potential CMIs, existing approaches still face challenges such as sparse association networks,...
Zhe-Qi Song, Shan-Chen Pang, Yun-Yin Li et al.· ACS Synthetic Biology· 0 citations
Experimental results demonstrate that MVCL-IB consistently outperforms competing methods across multiple evaluation metrics, and suggest that MVCL-IB provides an effective framework for prioritizing potential metabolite-disease associations.
This approach efficiently decodes the complex interactive topologies between lncRNAs and human diseases through topology-aware network representation and equilibrium-driven distribution alignment and provides more effective theoretical guidance for interpreting lncRNA-mediated cellular control systems and discovering p...
Jia-Jia Liu, Mu-Gang Lin, Ling-ling Zhu et al.· Bio Systems· 0 citations
CircRNAs are emerging regulators of human diseases, often functioning through miRNA-mediated regulatory networks. However, experimentally validated circRNA–disease associations remain limited, hindering systematic investigation of circRNA functions and disease mechanisms. Here, we propose CSDPCDA, a miRNA-mediated cros...
Xin Wang, Meng-Yuan Zhao, Yi-Xuan Zhao et al.· International Journal of Mol...· 0 citations
Experimental results show that MVGSCA effectively integrates heterogeneous biological information and achieves superior prediction performance, offering valuable insights into cancer resistance mechanisms and supporting drug discovery efforts.
Ru Nie, Ying Fu, Zhengwei Li et al.· IEEE transactions on computa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.